Quality of life in heart patients in Iran: A systematic review and meta-analysis method | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X


süperbetin giriş

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

agariookey oyna istanbul okey


Quality of life in heart patients in Iran: A systematic review and meta-analysis method

Author(s): Yousof Mohsenzadeh, Diana Sarokhani, Farhad Hemmati, Mandana Sarokhani, Alireza Akbarzadeh Baghban and Kourosh Sayehmiri

It is predicted that approximately 25 million deaths will occur due to cardiovascular disease per year 2010. Since this disease affects people's quality of life, The purpose of this study is to investigate the quality of life of cardiac patients in Iran using Meta-Analysis method. The search was done using keywords of Quality of Life, Cardiac, Iran in the foreign databases of Pub, Scopus, med, ISI, Google Scholar and native databases such as Sid, Medlib, Iran medex, Magiran. The data was analyzed using Meta-Analysis (Random Effects Model). The heterogeneity of the studies was investigated using the I2 index. Data was analyzed using STATA Ver.11 software. SF-36 questionnaires were used in the investigated studies. Among the 13 attempted studies with the sample size of 1581 people done through 2003 to 2015, the average quality of life of cardiac patients was 42.09 (Confidence interval 95%: 19.90 to 64.29). the mean score of quality of life of heart patients is 45/64 from social dimension, 43/46 from physical dimension, 48/24 from mental dimension, and 51/54 from vitality dimension. Also, the prevalence of excellent, fair and bad quality of life among the cardiac patients was 28%, 52%, and 22%. The quality of life of cardiac patients is moderate.


rokettube brazzers

wormax io